His scientific interests lie mostly in Biochemistry, Molecular biology, Peptide sequence, Glucocerebrosidase and Protein subunit. His studies in Complementary DNA, Amino acid, Sphingolipid Activator Proteins, Prosaposin and Molecular mass are all subfields of Biochemistry research. His Molecular biology study combines topics in areas such as Protein primary structure, Ms analysis, Sample preparation, Analytical chemistry and Proteomics.
The concepts of his Peptide sequence study are interwoven with issues in Metabolite, Angiotensin II, Binding protein and Structural gene. His Glucocerebrosidase research integrates issues from Gaucher's disease, Allele, Null allele and Genotype. His Protein subunit research incorporates themes from Cerebral cortex, Alpha-2 adrenergic receptor, Nucleic acid and GABAA receptor.
Brian M. Martin mostly deals with Biochemistry, Molecular biology, Optics, Peptide sequence and Resist. His Molecular biology research is multidisciplinary, incorporating elements of Nucleic acid sequence, Complementary DNA, Molecular cloning, Angiotensin II and Transcription. His Optics study incorporates themes from Reticle and Wafer.
In his research, Amyloidosis is intimately related to Antibody, which falls under the overarching field of Peptide sequence. Brian M. Martin interconnects Optoelectronics and Photolithography in the investigation of issues within Resist. His Glucocerebrosidase research incorporates elements of Gaucher's disease and Immunology.
Brian M. Martin mainly focuses on Biochemistry, Pathology, Amyloidosis, Immunology and Enzyme. His Biochemistry study frequently links to other fields, such as Chromatography. His studies in Chromatography integrate themes in fields like Molecular biology, Proteomics and Peptide.
His Amyloidosis study integrates concerns from other disciplines, such as Immunohistochemistry, Immunoglobulin light chain, Antibody and Amyloid. His Immunohistochemistry research focuses on Amyloid and how it connects with Peptide sequence. His biological study spans a wide range of topics, including Progressive myoclonus epilepsy, Null allele and Myoclonic epilepsy.
The scientist’s investigation covers issues in Biochemistry, Peptide, Proteomics, Pathology and Biomarker. His work blends Biochemistry and SNARE complex studies together. His Peptide study incorporates themes from Molecular biology, Chromatography, Fibrinogen and Analytical chemistry.
He combines subjects such as Ms analysis, Sample preparation, Hepatocellular carcinoma, Melanoma and Biomarker discovery with his study of Molecular biology. The concepts of his Analytical chemistry study are interwoven with issues in Peptide sequence and Alpha globulin. His Pathology research is multidisciplinary, incorporating elements of Allele, Genotype and Myoclonic epilepsy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
Shoji Tsuji;Prabhakara V. Choudary;Brian M. Martin;Barbara K. Stubblefield.
The New England Journal of Medicine (1987)
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin
Stephen J. Savarino;Alessio Fasano;John Watson;Brian M. Martin.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.
V. L. J. Tybulewicz;V. L. J. Tybulewicz;M. L. Tremblay;M. L. Tremblay;LaMarca;R. Willemsen.
Isolation, partial amino acid sequence, and immunohistochemical localization of a brain-specific calcium-binding protein
Lois Winsky;Hiroyasu Nakata;Brian M. Martin;David M. Jacobowitz.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene.
T. E. Howard;Shaw-Yung Shai;K. G. Langford;B. M. Martin.
Molecular and Cellular Biology (1990)
Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.
Shoji Tsuji;Brian M. Martin;John A. Barranger;Barbara K. Stubblefield.
Proceedings of the National Academy of Sciences of the United States of America (1988)
Mouse angiotensin-converting enzyme is a protein composed of two homologous domains.
K E Bernstein;B M Martin;A S Edwards;E A Bernstein.
Journal of Biological Chemistry (1989)
Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.
Eduard Orvisky;Joseph K Park;Mary E LaMarca;Edward I Ginns.
Molecular Genetics and Metabolism (2002)
Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
P Montpied;A L Morrow;J W Karanian;E I Ginns.
Molecular Pharmacology (1991)
CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide.
Michael R. Ruff;Brian M. Martin;Edward I. Ginns;William L. Farrar.
FEBS Letters (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: